CIC level was also negligible in a well-established mouse glioma 261 (GL261) cell line that harbors mutations in the K-Ras and p53 genes, frequently used for GBM therapy26, compared to normal mouse astrocytes (Figure 1g). The gene discussed is KRAS; the disease is central nervous system cancer.